Advertisement

Cartilage oligomeric matrix protein on the spot for liver fibrosis evaluation: Too early or too late?

      We would like to thank Huang et al. [
      • Huang R.
      • Xia J.
      • Yan X.
      • et al.
      Serum COMP levels as a novel non-invasive biomarker for liver fibrosis in patients with chronic viral hepatitis? It is too early.
      ] for their interest and valid comments regarding our recent study published in the March issue of the journal on the potential use of serum cartilage oligomeric matrix protein (COMP) levels as a new non-invasive marker of fibrosis in patients with chronic viral hepatitis (CVH) [
      • Zachou K.
      • Gabeta S.
      • Shums Z.
      • et al.
      COMP serum levels: a new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis.
      ].

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Huang R.
        • Xia J.
        • Yan X.
        • et al.
        Serum COMP levels as a novel non-invasive biomarker for liver fibrosis in patients with chronic viral hepatitis? It is too early.
        Eur J Intern Med. 2017;
        • Zachou K.
        • Gabeta S.
        • Shums Z.
        • et al.
        COMP serum levels: a new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis.
        Eur J Intern Med. 2017; 38: 83-88https://doi.org/10.1016/j.ejim.2017.01.007
        • Norman G.L.
        • Gatselis N.K.
        • Shums Z.
        • et al.
        Cartilage oligomeric matrix protein: a novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinoma.
        World J Hepatol. 2015; 7: 1875-1883
        • Williams F.M.
        • Spector T.D.
        Biomarkers in osteoarthritis.
        Arthritis Res Ther. 2008; 10: 101https://doi.org/10.1186/ar2344
        • Skoumal M.
        • Haberhauer G.
        • Feyertag J.
        • Kittl E.M.
        • Bauer K.
        • Dunky A.
        Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment.
        Rheumatol Int. 2006; 26: 1001-1004https://doi.org/10.1007/s00296-006-0117-4
        • Gardner H.
        • Shearstone J.R.
        • Bandaru R.
        • et al.
        Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts.
        Arthritis Rheum. 2006; 54: 1961-1973https://doi.org/10.1002/art.21894